US Stock MarketDetailed Quotes

SCPH scPharmaceuticals

Watchlist
  • 4.070
  • -0.080-1.93%
Close Nov 1 16:00 ET
  • 4.070
  • 0.0000.00%
Post 16:03 ET
203.62MMarket Cap-2608P/E (TTM)

scPharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
391.70%8.05M
195.78%6.1M
13.59M
6.1M
3.8M
1.64M
2.06M
0
0
0
Operating revenue
391.70%8.05M
195.78%6.1M
--13.59M
--6.1M
--3.8M
--1.64M
--2.06M
--0
--0
--0
Cost of revenue
549.72%2.3M
195.04%1.79M
3.81M
1.77M
1.08M
354K
605K
0
0
0
Gross profit
348.13%5.75M
196.09%4.32M
9.78M
4.32M
2.72M
1.28M
1.46M
0
0
0
Operating expense
34.30%20.19M
55.03%20.17M
80.26%65.18M
106.06%19.58M
75.65%17.56M
59.54%15.03M
79.72%13.01M
40.02%36.16M
41.38%9.5M
69.26%10M
Selling and administrative expenses
44.74%17.51M
60.12%17.45M
158.77%53.37M
126.34%16.24M
125.19%14.14M
182.68%12.1M
276.63%10.9M
110.79%20.62M
227.52%7.18M
183.90%6.28M
-General and administrative expense
----
----
158.77%53.37M
----
----
----
----
110.79%20.62M
----
----
Research and development costs
-8.76%2.68M
28.83%2.73M
-23.97%11.81M
43.51%3.34M
-7.99%3.42M
-42.94%2.93M
-51.32%2.12M
-3.15%15.53M
-48.65%2.33M
0.65%3.72M
Operating profit
-4.98%-14.43M
-37.23%-15.86M
-53.21%-55.4M
-60.57%-15.26M
-48.46%-14.84M
-45.91%-13.75M
-59.59%-11.55M
-40.02%-36.16M
-41.38%-9.5M
-69.26%-10M
Net non-operating interest income expense
-127.20%-1.47M
-89.47%-1.22M
-43.83%-3.02M
12.80%-967K
-423.45%-759K
-90.29%-647K
-27.92%-646K
16.90%-2.1M
-80.62%-1.11M
77.93%-145K
Non-operating interest income
-51.28%664K
-33.31%877K
324.27%5.1M
32.35%1.13M
460.78%1.3M
1,173.83%1.36M
10,015.38%1.32M
2,355.10%1.2M
12,042.86%850K
2,220.00%232K
Non-operating interest expense
6.17%2.13M
7.14%2.1M
146.00%8.12M
6.79%2.09M
446.42%2.06M
349.66%2.01M
278.57%1.96M
28.23%3.3M
215.46%1.96M
-43.48%377K
Other net income (expense)
-597.49%-1.19M
200.20%2.97M
154.23%3.61M
76.96%2.41M
-63.64%-36K
273.44%239K
6,971.43%990K
350.16%1.42M
7,917.65%1.36M
-320.00%-22K
Other non- operating income (expenses)
-597.49%-1.19M
200.20%2.97M
154.23%3.61M
76.96%2.41M
-63.64%-36K
273.44%239K
6,971.43%990K
350.16%1.42M
7,917.65%1.36M
-320.00%-22K
Income before tax
-20.74%-17.09M
-25.85%-14.11M
-48.79%-54.81M
-49.35%-13.81M
-53.85%-15.63M
-45.96%-14.15M
-45.00%-11.21M
-31.40%-36.84M
-26.37%-9.25M
-55.10%-10.16M
Income tax
Net income
-20.74%-17.09M
-25.85%-14.11M
-48.79%-54.81M
-49.35%-13.81M
-53.85%-15.63M
-45.96%-14.15M
-45.00%-11.21M
-31.40%-36.84M
-26.37%-9.25M
-55.10%-10.16M
Net income continuous Operations
-20.74%-17.09M
-25.85%-14.11M
-48.79%-54.81M
-49.35%-13.81M
-53.85%-15.63M
-45.96%-14.15M
-45.00%-11.21M
-31.40%-36.84M
-26.37%-9.25M
-55.10%-10.16M
Minority interest income
Net income attributable to the parent company
-20.74%-17.09M
-25.85%-14.11M
-48.79%-54.81M
-49.35%-13.81M
-53.85%-15.63M
-45.96%-14.15M
-45.00%-11.21M
-31.40%-36.84M
-26.37%-9.25M
-55.10%-10.16M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-20.74%-17.09M
-25.85%-14.11M
-48.79%-54.81M
-49.35%-13.81M
-53.85%-15.63M
-45.96%-14.15M
-45.00%-11.21M
-31.40%-36.84M
-26.37%-9.25M
-55.10%-10.16M
Basic earnings per share
-22.22%-0.44
-20.00%-0.36
-9.23%-1.42
-16.67%-0.35
-10.81%-0.41
-2.86%-0.36
-7.14%-0.3
-27.45%-1.3
-11.11%-0.3
-54.17%-0.37
Diluted earnings per share
-22.22%-0.44
-20.00%-0.36
-9.23%-1.42
-16.67%-0.35
-10.81%-0.41
-2.86%-0.36
-7.14%-0.3
-27.45%-1.3
-11.11%-0.3
-54.17%-0.37
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 391.70%8.05M195.78%6.1M13.59M6.1M3.8M1.64M2.06M000
Operating revenue 391.70%8.05M195.78%6.1M--13.59M--6.1M--3.8M--1.64M--2.06M--0--0--0
Cost of revenue 549.72%2.3M195.04%1.79M3.81M1.77M1.08M354K605K000
Gross profit 348.13%5.75M196.09%4.32M9.78M4.32M2.72M1.28M1.46M000
Operating expense 34.30%20.19M55.03%20.17M80.26%65.18M106.06%19.58M75.65%17.56M59.54%15.03M79.72%13.01M40.02%36.16M41.38%9.5M69.26%10M
Selling and administrative expenses 44.74%17.51M60.12%17.45M158.77%53.37M126.34%16.24M125.19%14.14M182.68%12.1M276.63%10.9M110.79%20.62M227.52%7.18M183.90%6.28M
-General and administrative expense --------158.77%53.37M----------------110.79%20.62M--------
Research and development costs -8.76%2.68M28.83%2.73M-23.97%11.81M43.51%3.34M-7.99%3.42M-42.94%2.93M-51.32%2.12M-3.15%15.53M-48.65%2.33M0.65%3.72M
Operating profit -4.98%-14.43M-37.23%-15.86M-53.21%-55.4M-60.57%-15.26M-48.46%-14.84M-45.91%-13.75M-59.59%-11.55M-40.02%-36.16M-41.38%-9.5M-69.26%-10M
Net non-operating interest income expense -127.20%-1.47M-89.47%-1.22M-43.83%-3.02M12.80%-967K-423.45%-759K-90.29%-647K-27.92%-646K16.90%-2.1M-80.62%-1.11M77.93%-145K
Non-operating interest income -51.28%664K-33.31%877K324.27%5.1M32.35%1.13M460.78%1.3M1,173.83%1.36M10,015.38%1.32M2,355.10%1.2M12,042.86%850K2,220.00%232K
Non-operating interest expense 6.17%2.13M7.14%2.1M146.00%8.12M6.79%2.09M446.42%2.06M349.66%2.01M278.57%1.96M28.23%3.3M215.46%1.96M-43.48%377K
Other net income (expense) -597.49%-1.19M200.20%2.97M154.23%3.61M76.96%2.41M-63.64%-36K273.44%239K6,971.43%990K350.16%1.42M7,917.65%1.36M-320.00%-22K
Other non- operating income (expenses) -597.49%-1.19M200.20%2.97M154.23%3.61M76.96%2.41M-63.64%-36K273.44%239K6,971.43%990K350.16%1.42M7,917.65%1.36M-320.00%-22K
Income before tax -20.74%-17.09M-25.85%-14.11M-48.79%-54.81M-49.35%-13.81M-53.85%-15.63M-45.96%-14.15M-45.00%-11.21M-31.40%-36.84M-26.37%-9.25M-55.10%-10.16M
Income tax
Net income -20.74%-17.09M-25.85%-14.11M-48.79%-54.81M-49.35%-13.81M-53.85%-15.63M-45.96%-14.15M-45.00%-11.21M-31.40%-36.84M-26.37%-9.25M-55.10%-10.16M
Net income continuous Operations -20.74%-17.09M-25.85%-14.11M-48.79%-54.81M-49.35%-13.81M-53.85%-15.63M-45.96%-14.15M-45.00%-11.21M-31.40%-36.84M-26.37%-9.25M-55.10%-10.16M
Minority interest income
Net income attributable to the parent company -20.74%-17.09M-25.85%-14.11M-48.79%-54.81M-49.35%-13.81M-53.85%-15.63M-45.96%-14.15M-45.00%-11.21M-31.40%-36.84M-26.37%-9.25M-55.10%-10.16M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -20.74%-17.09M-25.85%-14.11M-48.79%-54.81M-49.35%-13.81M-53.85%-15.63M-45.96%-14.15M-45.00%-11.21M-31.40%-36.84M-26.37%-9.25M-55.10%-10.16M
Basic earnings per share -22.22%-0.44-20.00%-0.36-9.23%-1.42-16.67%-0.35-10.81%-0.41-2.86%-0.36-7.14%-0.3-27.45%-1.3-11.11%-0.3-54.17%-0.37
Diluted earnings per share -22.22%-0.44-20.00%-0.36-9.23%-1.42-16.67%-0.35-10.81%-0.41-2.86%-0.36-7.14%-0.3-27.45%-1.3-11.11%-0.3-54.17%-0.37
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data